Indraprastha University to lead project to develop low-cost test for detecting Covid-19 antibodies – education

The Guru Gobind Singh Indraprastha University will lead a project to develop a low-cost test for fast detection of COVID-19 antibodies, an announcement from the college stated on Sunday.

The translational project of Rs 98 lakh was submitted to BIRAC-DBT by Dr Gaurav Pandey of the University Faculty of Biotechnology (USBT). It has been chosen for funding in response to a analysis consortium name on COVID -19, the assertion added.

“It’s a matter for pleasure that IP University will lead a multi-institutional project to develop the indigenous know-how for fast detection of COVID -19 antibodies with minimal infrastructural requirement,” it stated.

The Biotechnology Business Analysis Council (BIRAC), a public sector enterprise arrange by the Division of Biotechnology (DBT) by its COVID -19 analysis consortium after aggressive analysis, will fund the college and its companions to “develop a low-cost utterly indigenous test for SARS COV2 antibody testing, which can be utilized for giant-scale screening of pandemic inhabitants”, it stated.

At present, most of those antibody checks both as full checks or with a few of key elements reminiscent of antigens depend on imports, it stated.

Dr Gaurav Pandey from IP University, Dr Anurag Rathore from Indian Institute of Expertise, Delhi and Mr Prateek Mittal from Medsource Ozone kind a translational staff which is able to “develop a scalable course of to produce the required antigens elements and manufacture the purpose of care lateral circulation immunoassay (LFIA) system”.

The LFIA test gives the ends in most 15-20 minutes and is sort of useful resource impartial, the assertion stated.

“It doesn’t require excessive-finish tools and can be utilized in distant settings. The partnership with an industrial companion Medsource Ozone Pvt. Ltd will guarantee sooner diffusion of know-how, manufacturing and commercialization,” it added. PTI SLB SNE